gated by Asai et al. 25 and Hashimoto et al. 26 . Asai et al. demonstrated the presence of fucoxanthinol in the plasma of all participants after one week of a daily intake of stirfried wakame Undaria pinnatifida . They served stirfried wakame containing 6.1 mg fucoxanthin per day for one week, and found 0.8 nM concentrated fucoxanthinol in human plasma. On the other hand, Hashimoto et al. also demonstrated the presence of fucoxanthinol in the human plasma 4 h after kombu Laminaria japonica extract intake. They served 10 mL of kombu extract containing 31 mg fucoxanthin provided by Oryza Oil & Fat Chemical dissolved in medium-chain triacylglycerol, and found 44.2 nM concentrated fucoxanthinol in human plasma 4 h after a single intake. From these results, the bioavailability of fucoxanthin or fucoxanthinol seems to be lower than that of other dietary carotenoids such as β-carotene 68 nM 27 , lutein 380 nM 27 , and astaxanthin 321 nM 28 . The abAbstract: Novel fucoxanthin derivatives that could change the size of mixed micelles were synthesized. The mixed micelles under consideration consist of a bile acid and some additives. To change the affinity against a bile acid, we designed the synthesis of a fucoxanthin-lithocholic acid complex. Lithocholic acid is one of the bile acids. The 3-OH on lithocholic acid was protected by a levulinyl group, and the protected lithocholic acid was selectively coupled via an ester linkage to the 3-OH on fucoxanthin to obtain levulinyl-protected lithocholyl fucoxanthin (LevLF). The levulinyl group was then selectively deprotected using hydrazine to obtain a lithocholyl fucoxanthin (LF). The average sizes of the micelles that contained these compounds (fucoxanthin, LevLF, and LF) with a bile acid (sodium taurocholate) were measured. The LevLF induced larger micelles than fucoxanthin or LF. Interestingly, the addition of 1-oleoyl-rac-glycerol induced a more efficient change in the micelle size. The large micelles grew larger, and the small micelles became smaller. Triple-mixed micelles with LevLF, sodium taurocholate, and 1-oleoyl-rac-glycerol formed the largest micelle with a diameter of 68 nm. On the other hand, triple-mixed micelles using LF, sodium taurocholate, and 1-oleoyl-rac-glycerol made the smallest micelles with diameters as low as 12 nm. We also investigated the hydrolysis of these compounds with enzymes (esterase from porcine liver, lipase from porcine pancreas, and cholesterol esterase from Pseudomonas sp.). The ester linkage between the lithocholic acid and fucoxanthin of LevLF was hydrolyzed with cholesterol esterase. In addition, the intestinal absorption was examined with Caco-2 cells, and no advantageous change in absorption efficiency was observed by chemically modifying the fucoxanthin unless different micelles sizes and increasing hydrophobicity are induced.
Key words: fucoxanthin, fucoxanthin derivatives, levulinyl protected lithocholyl fucoxanthin, lithocholyl fucoxanthin sorption of fucoxanthin from a food requires several steps. These include releasing fucoxanthin from the food matrix, solubilizing into mixed bile salt micelles, and uptake by the intestinal epithelial cells 29 . With the aim of improving intestinal absorption of fucoxanthin, we focused on the formation of mixed bile salt micelles. The micelle size is one of the important factors that affect absorption by intestinal epithelial cells 30 33 . We designed and successfully synthesized fucoxanthin derivatives for the purpose of changing their affinity to bile acid and investigated the size of the resulting micelles relative to their structures. In addition, an enzymatic hydrolysis assay and an uptake assay by the Caco-2 cell line were reported.
EXPERIMENTAL PROCEDURES

Materials
Dry wakame from China was purchased from a local market in Tsukuba, Japan. Esterase from porcine liver and lipase from porcine pancreas were purchased from the Sigma-Aldrich Chemical Co. LLC Tokyo, Japan . Cholesterol esterase from Pseudomonas sp. was purchased from the Wako Pure Chemical Industries Ltd Osaka, Japan . All of the reagents and solvents used were reagent grade. 
Apparatus
Puri cation of fucoxanthin 3
Fucoxanthin 3 was purified from dry wakame. The efficiency of extraction solvents was examined. We compared ethanol and the mixed solvent chloroform/methanol/water 5/4/1 for the efficiency of fucoxanthin 3 extraction. The fucoxanthin 3 content was determined by the area under the peak on analytical reverse-phase HPLC condition A detected at 450 nm. After 1 h and 15 h for ethanol extraction, the extracted fucoxanthin 3 was 0.12 and 0.17 mg/g dry wakame, respectively. On the other hand, in the case of the mixed solvent chloroform/methanol/water 5/4/1 extraction, the extracted fucoxanthin 3 was 0.91 and 1.2 mg/g dry wakame, respectively. Based on these observed extraction efficiencies we used the mixed solvent chloroform/methanol/water 5/4/1 for fucoxanthin 3 extraction. Dry wakame from China purchased in Japan was milled. The powdered dry wakame 427 g in chloroform/methanol/ water 500 mL/400 mL/100 mL was stirred at room temperature for 64 h in the absence of light. The insoluble materials were filtered off by using celite, and washed with chloroform/methanol/water 5/4/1 several times. Then, the combined filtrate and washings were concentrated. Chromatography of the residue on silica gel with ethyl acetate/ toluene 1/5 gave fucoxanthin 3; 464 mg, 1.09 mg/g dry wakame . The 1 H-NMR and 13 C-NMR spectra were identical to those previous reported 34 .
2. Table 1 . All of the mixtures were clearly dissolved in water, filtered through 0.2 μm pore size filters, and the average diameter of the micelles was measured by DLS. All experiments were done in dim light. The results are shown in Table 1 .
Enzymatic hydrolysis assay
The following three types of solutions of micelles in water as described in 2.5 Measurements of the size of micelles were used for an enzyme assay: 1: 2 mM sodium taurocholate and 100 μM fucoxanthin 3 , 2: 2 mM sodium taurocholate and 100 μM LevLF 4 , 3: 2 mM sodium taurocholate and 100 μM LF 5 . To a solution of each type of micelle 10 μL was added phosphate buffered saline PBS 60 μL and to each, one of the following three types of enzymes, 1: 180 units/mL esterase from porcine liver in PBS 30 μL , 2: 180 units/mL lipase from porcine pancreas in PBS 30 μL , 3: 180 units/mL cholesterol esterase from Pseudomonas sp. in PBS 30 μL . After 62 h at 37 , the reaction mixtures were analyzed by analytical reversephase HPLC condition A detected at 450 nm. The eluates producing the observed peaks were collected and analyzed by ESI-FT-MS to deduce the structures Fig. 2 . In addition, the yields were calculated from the area under the peak. The results are shown in 40 ,000 U/L penicillin, 40 mg/L streptomycin and 0.1 nM nonessential amino acids. Cells were kept at 37 in a humidified atmosphere of 95 air and 5 CO 2 . The cells were grown by passaging twice per week. To obtain differentiated Caco-2 cell monolayers, the cells at passages of 33-60 were seeded into 24-well plates at a density of 5 10 4 cells per well containing 0.5 mL of the culture medium, and the medium was replaced with fresh medium twice per week for 22 days.
Cellular uptake
Fucoxanthin derivatives were delivered to Caco-2 cells as the mixed micelles referred to in the previously described method 29 . Briefly, the final mixed micelles concentration of each component in the serum-free DMEM medium was as follows: 2 mM sodium taurocholate, 100 μM 1-oleoyl-rac-glycerol, 33.3 μM oleic acid, 50 μM 1-palmitoyl-sn-glycero-3-phosphocholine, and 1.0 μM each carotenoids fucoxanthin 3 , LevLF 4 , or LF 5 . The differentiated monolayers of the Caco-2 cells in a 24-well plate were supplemented with 0.5 mL of the each mixed micelles. After incubation in the cell culture section for 2 h, the monolayers were washed with PBS containing 10 mM sodium taurocholate and then washed twice with PBS. They were homogenized in 1 mL of PBS containing 0.01 mL of 0.2 mM α-tocopherol/methanol as an antioxidant, with a probe-type sonicator. An aliquot of each homogenized cell was taken to determine the protein content 37 . To extract the carotenoids, 0.8 mL ethanol, 0.8 mL of ethyl acetate, and 0.8 mL of n-hexane were added to these homogenized cell 0.8 mL , and the solution was agitated with a Vortex Mixer after each addition. The resultant upper phase of n-hexane-ethyl acetate was withdrawn. The lower phase was similarly extracted with 0.8 mL of ethyl acetate and 0.8 mL of n-hexane. The combined extract was dried in a centrifugal evaporator. The extract was then dissolved in 0.2 mL of dimethyl sulfoxide/methanol/water 2/7/1 for fucoxanthin 3 or dimethyl sulfoxide/methanol 2/7 for LevLF 4 and LF 5 . The residues were analyzed by analytical reverse-phase HPLC condition B. The results are shown in Fig. 3 . The data were tested for homogeneity of variances by the Bartlett test. When homogeneous variances were confirmed, the data were analyzed by one-way ANOVA, followed by the Tukey-Kramer test. P-values 0.05 were considered significant.
RESULTS AND DISCUSSION
Synthesis of fucoxanthin derivatives
We designed novel fucoxanthin derivatives to change the affinity for bile acid. Lithocholic acid, one of the bile acids, was selected due to its high hydrophobicity. It contains only one hydroxyl group, while other bile acids, cholic acid, chenodeoxycholic acid, and deoxycholic acid, contain three, two, and two hydroxyl group, respectively. There was a case in which the compounds with increased hydrophobicity also induced high absorption 38 . We designed lithocholic acid-linked fucoxanthin via ester linkage compounds 4 and 5 with the aim of releasing fucoxanthin or fucoxanthinol by intracellular hydrolase enzyme. The difference between compounds 4 and 5 is the hydrophobicity. The difference in hydrophobicity induces the difference in affinity for bile acid. The 3-OH of lithocholic acid 1 was protected by the levulinyl group using levulinic anhydride to synthesize levulinyl-protected lithocholic acid 2 in 72 yield Fig. 1 . A significant 1 H NMR signal of compound 2 was H-3 δ 4.71 . The levulinyl group has two roles. It provides hydrophobicity and an orthogonal protecting group for the hydroxyl group. It could be selectively removed by hydrazine without influencing the other ester group. The purified fucoxanthin 3 from wakame was coupled with protected lithocholic acid 2 by N,N -diisopropylcarbodiimide DIC and 4-dimethylamino pyridine DMAP in dichloromethane to obtain lev-lithocholyl-fucoxanthin 4: LevLF in 88 yield. The coupling position was confirmed and ESI-FT-MS. The maximum absorption wavelengths λ max for these compounds 4 and 5 were determined to be 448 nm and 450 nm, respectively, and the molecular absorption coefficients ε in ethanol for them were also determined to be 50400 and 69400, respectively.
Measurements of micelles size
The micelle size is one of the important factors affecting absorption by intestinal epithelial cells. The average size of micelles that contain these compounds fucoxanthin 3 , LevLF 4 , and LF 5 with a bile acid sodium taurocholate were measured by DLS Table 1 . In addition, we verified the effect of 1-oleoyl-rac-glycerol as an additive for micelles. As the results show in Table 1 , comparing with single micelle of sodium taurocholate 44 nm , the mixed micelles of each fucoxanthin 3; 33 nm and LF 5; 33 nm led to smaller micelles entry 3 and 5 , whereas LevLF 4; 59 nm led to larger micelles entry 4 . Interestingly, the addition of 1-oleoyl-rac-glycerol induced a more efficient change in the micelle size. The large micelles grew larger, and the small micelles became smaller. Triple-mixed micelles with LevLF 4 , sodium taurocholate, and 1-oleoylrac-glycerol formed the largest micelle with a diameter of 68 nm. On the other hand, triple-mixed micelles using LF 5 , sodium taurocholate, and 1-oleoyl-rac-glycerol made the smallest micelles with diameters as low as 12 nm. We succeeded in inducing different micelle sizes merely based on whether the 3-OH of LF 5 was protected or not by the levulinyl group. The interaction between these compounds fucoxanthin 3 , LevLF 4 , and LF 5 and a bile acid sodium taurocholate was confirmed by the measurements of full width at half maximum FWHM 32 in Table 1 . FWHM values of the micelles entries 3 to 8 increased in comparison with the ethanol solutions of each compound 3, 4, and 5 , indicating these compounds formed a complex in the micellar inside.
Enzymatic hydrolysis assay
The enzymatic hydrolysis of fucoxanthin 3 , LevLF 4 , and LF 5 was investigated to determine the fate of these compounds after absorption by intestinal epithelial cells. The metabolic fate of fucoxanthin 3 in mice revealed its conversion into two metabolites, fucoxanthinol 6 and amarouciaxanthin A. By using PC-3 cells, fucoxanthin 3 , fucoxanthinol 6 , and amarouciaxanthin A demonstrated IC 50 values of 3.0 μM, 2.0 μM, and 4.6 μM, respectively, indicating that fucoxanthinol 6 was the most active form 39 .
We designed LevLF 4 and LF 5 consisting of ester linkages to be able to release fucoxanthinol 6 by esterase. A compound that could release fucoxanthinol 6 has the possibility of being a bioactive compound. We tested three types of enzymes; esterase from porcine liver, lipase from porcine pancreas, and cholesterol esterase from Pseudomonas sp. As the results show in Table 2 , fucoxanthin 3 was hydrolyzed to fucoxanthinol 6 by esterase and cholesterol esterase as almost the same rate. On the other hand, LevLF 4 and LF 5 was effectively hydrolyzed by cholesterol esterase. Interestingly, LevLF 4 was the only one to have hydrolyzed by an enzyme the ester linkage between lithocholic acid and fucoxanthin. From the products ratio, the hydrolysis of LevLF 4 was projected in the following order; at the first step, the acetyl group of LevLF 4 was hydrolyzed to LevLF-OH 7 . In the second step, LevLF-OH 7 was hydrolyzed to fucoxanthinol 6 or LF-OH 8 . The levulinyl group of LevLF 4 was important for enzymatic hydrolysis of ester linkage between lithocholic acid and fucoxanthin because without the levulinyl protecting group, no fucoxanthinol production was induced entries 7 to 9 .
Cellular uptake of micellar fucoxanthin derivatives
To evaluate the efficiency of intestinal absorption for fucoxanthin derivatives, we used Caco-2 cells as a model of the intestinal epithelial cells. Fucoxanthin derivatives LevLF 4 and LF 5 were compared with fucoxanthin 3 for Caco-2 cell uptake. As the results show in Fig. 3 , unfortunately no advantage for uptake was observed as a result of the chemical modification. The fucoxanthin 3 -treated cells formed fucoxanthinol 6 , which is a hydrolysate of fucoxanthin 3 . The amount of fucoxanthinol 6 in the cells was one-half that of the fucoxanthin 3 . Similarly, the LevLF 4 -treated cells could possibly form fucoxanthin 3 , fucoxanthinol 6 , LF 5 , LF-OH 8 , and LevLF-OH 7 . On the other hands, LF 5 -treated cells could possibly form fucoxanthin 3 , fucoxanthinol 6 , and LF-OH 8 . However, only LevLF-OH 7 and LF-OH 8 as a hydrolysate from LevLF 4 and LF 5 was observed, respectively. In addition, the ratio of hydrolysate amount to the total uptake amounts was approximately 5 . These results suggested that the cholesterol esterase activity for the hydrolysis of LevLF 4 and LF 5 was low in the Caco-2 cells used in the present study as previously reported 40 .
CONCLUSION
We designed and successfully synthesized novel fucoxanthin derivatives to effect a change in their affinity to bile acids. We demonstrated the dependency on structural of different micelle sizes. Depending on the presence or absence of the hydroxyl-protecting group, the micelles sizes were changed. From the enzymatic hydrolysis assay, LevLF 4 could be hydrolyzed by the enzyme to release fucoxanthinol 6 , which is the active form of fucoxanthin 3 . In addition, this result showed the potential of LevLF 4 as a bio-active compound to release the fucoxanthinol 6 inside the cell. Unfortunately, from the Caco-2 cell uptake assay, no advantage was observed resulting from the chemical modification of fucoxanthin for absorption efficiency, unless different micelle sizes are induced and hydrophobicity is increased. From our results, the micelle size may not influence absorption efficiency for Caco-2 cells. However, from the Pa probability to be active values of PASS Prediction of Activity Spectra for Substances online approach www.pharmaexpert.ru/PASSOnline/ 41 45 , these fucoxanthin derivatives may have an adv a n t a g e c o m p a r e d w i t h f u c o x a n t h i n i n t h e i r chemopreventive activity, anticarcinogenic activity, and proliferative diseases treatment activity Table 3 . Continuous studies of these fucoxanthin derivatives are in progress and will be reported elsewhere. 0.891 a) Pa value was calculated by the PASS (Prediction of Activity Spectra for Substances) online approach (www.pharmaexpert.ru/PASSOnline/). Pa > 0.7 is shown. b) More active compound than fucoxanthin is marked.
